Urge Incontinence : News
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... talk with their physicians about any symptoms they may have of possible urological conditions. These include: Incontinence . More than 15 million Americans experience either stress incontinence -- the loss of urine during such activities as ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
More than 15 million Americans, primarily women, suffer from incontinence. About 25 percent of females and 15 percent of males over the age of 65 suffer from incontinence.
|
|
... up after placement of an Aris transobuturator sling. The group reported resolution of SUI in 90.61% of the patients, of urge incontinence in 61.81%, and only 2.51% (n=2) with de novo urgency symptoms. Each of the questionnaires used in the study, ...
|
|
... patients who underwent artificial urinary sphincter (AUS) placement for treatment of post-prostatectomy incontinence - with specific attention to postoperative voiding dysfunction. At a mean follow up of 21 months (range 3-82), nine (26%) patients ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
Bladder Health Month - the American Urological Association encourages people struggling with incontinence to see a doctor to learn the underlying cause of their incontinence and seek treatment instead of ...
|
|
... (causing hesitancy, weak urine stream, straining, prolonged voiding, intermittency, incomplete voiding, and incontinence) or irritative (causing nocturia, frequency, urgency, urge incontinence). Studies have shown that there is no well-defined ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
|
... is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Vimpat Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.